Ganye Pingchan Decoction (感夜平颤方) for Patients with Early-Moderate Parkinson's Disease Complicated with Rapid Eye Movement Sleep Behavior Disorder on Sleep and Blood Pressure Circadian Rhythm Disorders: A Randomized Controlled Trial
|更新时间:2026-02-04
|
Ganye Pingchan Decoction (感夜平颤方) for Patients with Early-Moderate Parkinson's Disease Complicated with Rapid Eye Movement Sleep Behavior Disorder on Sleep and Blood Pressure Circadian Rhythm Disorders: A Randomized Controlled Trial
Journal of Traditional Chinese MedicineVol. 67, Issue 3, Pages: 283-290(2026)
WU You,YE Qing,YUAN Canxing,et al.Ganye Pingchan Decoction (感夜平颤方) for Patients with Early-Moderate Parkinson's Disease Complicated with Rapid Eye Movement Sleep Behavior Disorder on Sleep and Blood Pressure Circadian Rhythm Disorders: A Randomized Controlled Trial[J].Journal of Traditional Chinese Medicine,2026,67(03):283-290.
WU You,YE Qing,YUAN Canxing,et al.Ganye Pingchan Decoction (感夜平颤方) for Patients with Early-Moderate Parkinson's Disease Complicated with Rapid Eye Movement Sleep Behavior Disorder on Sleep and Blood Pressure Circadian Rhythm Disorders: A Randomized Controlled Trial[J].Journal of Traditional Chinese Medicine,2026,67(03):283-290.DOI: 10.13288/j.11-2166/r.2026.03.010.
Ganye Pingchan Decoction (感夜平颤方) for Patients with Early-Moderate Parkinson's Disease Complicated with Rapid Eye Movement Sleep Behavior Disorder on Sleep and Blood Pressure Circadian Rhythm Disorders: A Randomized Controlled Trial
(感夜平颤方) for patients with early-moderate Parkinson's disease (PD) complicated with rapid eye movement sleep behavior disorder (RBD) on sleep and blood pressure circadian rhythm disorders.
Methods
2
A total of 80 patients with early-moderate PD patients with RBD were randomly assigned to either a treatment group or a control group, with 40 patients in each group. The control group received conventional western medicine plus placebo of
Ganye Pingchan Decoction
, while the treatment group received conventional western medicine combined with
Ganye Pingchan Decoction
. The course of treatment for both groups was 12 weeks. Changes in the Unified Parkinson's Disease Rating Scale (UPDRS), Hong Kong Rapid Eye Movement Sleep Behavior Disorder Questionnaire (RBDQ-HK), Parkinson's Disease Sleep Scale (PDSS), polysomnography (PSG), salivary melatonin (SM) secretion rhythms, and 24-hour ambulatory blood pressure before and after treatment were measured in both groups.
Results
2
Compared with the baseline data within group, the scores of RBDQ-HK and UPDRS decreased in both groups after treatment; the PDSS score increased in the treatment group but decreased in the control group; in the treatment group, sleep efficiency was improved, and the number and index of microarousals reduced; the proportion of N3 sleep stage increased, while rapid eye movement (REM) activity, REM intensity and REM density decreased in both groups; the median SM secretion level increased in both groups, and the amplitude of SM secretion elevated in the treatment group; in the treatment group, the nocturnal systolic blood pressure decline rate (n-SBP) increased, and the proportion of patients with non-dipper blood pressure rhythm raised (
P
<0.05). After treatment, the scores of UPDRS and RBDQ-HK, as well as the n
umber and index of microarousals in the treatment group were significantly lower than those in the control group; the daytime mean systolic blood pressure (d-SBP) and △n-SBP in the treatment group were higher than those in the control group (
P
<0.05).
Conclusion
2
Ganye Pingchan Decoction
can effectively regulate sleep and blood pressure circadian rhythms in patients with early-moderate PD complicated with RBD. It can improve sleep efficiency, reduce sleep fragmentation, regulate the circadian rhythm of SM secretion, increase the nocturnal systolic blood pressure decline rate, with good safety.
关键词
Keywords
references
NASSAN M , VIDENOVIC A . Circadian rhythms in neurodegenerative disorders [J]. Nat Rev Neurol , 2022 , 18 ( 1 ): 7 - 24 .
SHEN Y , LV QK , XIE WY , et al . Circadian disruption and sleep disorders in neurodegeneration [J]. Transl Neurodegener , 2023 , 12 ( 1 ): 8 .
TANNER CM , OSTREM JL . Parkinson's Disease [J]. N Engl J Med , 2024 , 391 ( 5 ): 442 - 452 .
SMILOWSKA K , VAN WAMELEN DJ , BLOEM BR . The multimodal effect of circadian interventions in Parkinson's disease: a narrative review [J]. Parkinsonism Relat Disord , 2023 , 110 : 105309.1 - 12 . doi: 10.1016/j.parkreldis.2023. 105309 http://dx.doi.org/10.1016/j.parkreldis.2023.105309 .
LIU Y , NIU L , LIU X , et al . Recent progress in non-motor features of Parkinson's disease with a focus on circadian rhythm dysregulation [J]. Neurosci Bull , 2021 , 37 ( 7 ): 1010 - 1024 .
TURKISTANI A , AL-KURAISHY HM , AL-GAREEB AI , et al . Blunted melatonin circadian rhythm in Parkinson's disease: express bewilderment [J]. Neurotox Res , 2024 , 42 ( 5 ): 38 .
LI T , CHENG C , JIA C , et al . Peripheral clock system abnormalities in patients with Parkinson's disease [J]. Front Aging Neurosci , 2021 , 13 : 736026 . doi: 10.3389/fnagi.2021.736026 http://dx.doi.org/10.3389/fnagi.2021.736026 .
GU SC , SHI R , GAOAG C , et al . Traditional Chinese medicine Pingchan granule for motor symptoms and functions in Parkinson's disease: a multicenter, randomized, double-blind, placebo-controlled study [J]. Phytomedicine , 2023 , 108 : 154497 . doi: 10.1016/j.phymed.2022. 154497 http://dx.doi.org/10.1016/j.phymed.2022.154497 .
O'HAGAN A , STEVENS JW , CAMPBELL MJ . Assu-rance in clinical trial design [J]. Pharm Stat , 2010 , 4 ( 3 ): 187 - 201 .
CHAUDHURI KR , PAL S , DIMARCO A , et al . The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease [J]. J Neurol Neurosurg Psychiatry , 2002 , 73 : 629 - 635 . doi: 10.1136/jnnp.73.6.629 http://dx.doi.org/10.1136/jnnp.73.6.629 .
MARTÍNEZ-MARTÍN P , GIL-NAGEL A , GRACIA LM , et al . Unified Parkinson's disease rating scale characte-ristics and structure. the cooperative multicentric group [J]. Mov Disord , 1994 , 9 : 76 - 83 . doi: 10.1002/mds. 870090112 http://dx.doi.org/10.1002/mds.870090112 .
STEFANI A , ANTELMI E , ARNALDI D , et al . From mechanisms to future therapy: a synopsis of isolated REM sleep behavior disorder as early synuclein-related disease [J]. Mol Neurodegener , 2025 , 20 ( 1 ): 19 .
CZEISLER CA , WEITZMAN E , MOORE-EDE MC , et al . Human sleep: its duration and organization depend on its circadian phase [J]. Science , 1980 , 210 ( 4475 ): 1264 - 1267 .
CARDINALI DP , GARAY A . Melatonin as a chronobiotic/cytoprotective agent in rem sleep behavior disorder [J]. Brain Sci , 2023 , 13 ( 5 ): 1 - 19 .
OHAYON MM , SCHENCK CH . Violent behavior during sleep: prevalence, comorbidity and consequences [J]. Sleep Med , 2010 , 11 ( 9 ): 941 - 946 .
HÖGL B , STEFANI A , VIDENOVIC A . Idiopathic REM sleep behaviour disorder and neurodegeneration:an update [J]. Nat Rev Neurol , 2018 , 14 ( 1 ): 40 - 55 .
OHNUKI T , UEDA M , YAMAMURA S . Molecular mechanism of the control of nyctinastic leaf-movement in Lespedeza cuneata G.Don [J]. Tetrahedron , 1998 , 54 ( 40 ): 12173 - 12184 .
YANG Y , WU Y , XU P , et al . Nyctinastic herbs decoction improves para-chlorophenylalanine-induced insomnia by regulating the expression level of neurotransmitters [J]. Ann Transl Med , 2021 , 9 ( 20 ): 1524 .
WILSON H , DERVENOULAS G , PAGANO G , et al . Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study [J]. Lancet Neurol , 2019 , 18 ( 8 ): 748 - 759 .
Professor ZHOU Shaohua's Experience in Staged Treatment of Parkinson's Disease Based on the "Disease-Symptom-Syndrome Integration" Approach
Effects of Bushen Zhichan Formula (补肾止颤方) on Ferroptosis of Dopaminergic Neurons and Nrf2-Regulated SLC7A11/GSH/GPX4 Signaling Pathway in Parkinson's Disease Model Rats
Effect of Bushen Huoxue Granule (补肾活血颗粒) on Dopamine Homeostasis and ERK/CREB/VMAT2 Signaling Pathways in the Striatum in Parkinson's Disease Model Mice
Efficacy and Safety of Acupuncture Combined with Levodopa in the Treatment of Parkinson's Disease: A Randomized Controlled Trial
Effect of Bushen Huoxue Granules (补肾活血颗粒) on the Nrf2/NLRP3 Inflammasome Axis in the Brain Substantia Nigra of Parkinson's Disease Model Mice
Related Author
XU Dinglin
WANG Jiayi
GE Liwei
GUO Chunli
周绍华
HU Yuying
CHEN Weiying
SONG Xi
Related Institution
Graduate School,Beijing University of Chinese Medicine
Xiyuan Hospital,China Academy of Chinese Medical Sciences
Guangxi University of Chinese Medicine
The First Affiliated Hospital of Guangxi University of Chinese Medicine